Study of Thyroid Hormones for Vitiligo Patients in AL-Anbar Governorate
Keywords:Vitiligo, Thyroid hormone, Autoimmune thyroid,T3, T4, TSH.
Vitiligo is a common acquired depigmentation disorder characterized by the loss of functional skin and mucosal melanocytes the reported incidence is 0.5% to 2% worldwide. Its pathogenesis is mostly consider autoimmune and this pigmentary disorder is strongly associated with autoimmune thyroid disorders. To evaluate the serum thyroid hormone in vitiligo patients of Al-Anbar governorate and to compare the results with other external studies. The study group included 80 patients with vitiligo, and 40 healthy volunteers. Blood thyroid hormone was determined using Monobind kits from reliable USA company. Their ages ranged form 1 to 70 years. Family history of vitiligo was positive in a percentage of (30%) of the patients. The mean levels of serum thyroid hormone (T3, T4) in patients with vitiligo were found to be no significant difference than those of healthy individuals. The TSH level in patient with vitiligo were found to be significantly higher than those of healthy individuals. This study strengthens the relationship between the thyroid hormones intake, formation, and metabolism with the pathogenesis of vitiligo. Therefore it is concluded that vitiligo patients should be evaluated for thyroid hormones.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions